Literature DB >> 33420920

Interactions between commensal bacteria and viral infection: insights for viral disease control in farmed animals.

Chao Ran1, Yu Li2,3, Xufa Ma3, Yadong Xie2, Mingxu Xie2, Yuting Zhang2, Wei Zhou2, Yalin Yang1, Zhen Zhang1, Li Zhou4, Kaijian Wei5, Zhigang Zhou6.   

Abstract

Viral diseases cause serious economic loss in farmed animals industry. However, the efficacy of remedies for viral infection in farmed animals is limited, and treatment strategies are generally lacking for aquatic animals. Interactions of commensal microbiota and viral infection have been studied in recent years, demonstrating a third player in the interaction between hosts and viruses. Here, we discuss recent developments in the research of interactions between commensal bacteria and viral infection, including both promotion and inhibition effect of commensal bacteria on viral pathogenesis, as well as the impact of viral infection on commensal microbiota. The antiviral effect of commensal bacteria is mostly achieved through priming or regulation of the host immune responses, involving differential microbial components and host signaling pathways, and gives rise to various antiviral probiotics. Moreover, we summarize studies related to the interaction between commensal bacteria and viral infection in farmed animals, including pigs, chickens, fish and invertebrate species. Further studies in this area will deepen our understanding of antiviral immunity of farmed animals in the context of commensal microbiota, and promote the development of novel strategies for treatment of viral diseases in farmed animals.
© 2021. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  commensal bacteria; farmed animals; intestinal microbiota; probiotics; virus

Mesh:

Substances:

Year:  2021        PMID: 33420920     DOI: 10.1007/s11427-020-1721-5

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  75 in total

1.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

2.  Regulation of immunity and disease resistance by commensal microbes and chromatin modifications during zebrafish development.

Authors:  Jorge Galindo-Villegas; Diana García-Moreno; Sofia de Oliveira; José Meseguer; Victoriano Mulero
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  Effect of probiotics enriched diet on Paralichthys olivaceus infected with lymphocystis disease virus (LCDV).

Authors:  Ramasamy Harikrishnan; Chellam Balasundaram; Moon-Soo Heo
Journal:  Fish Shellfish Immunol       Date:  2010-08-03       Impact factor: 4.581

4.  Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.

Authors:  Kuldeep S Chattha; Anastasia N Vlasova; Sukumar Kandasamy; Gireesh Rajashekara; Linda J Saif
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

5.  Antibiotic growth promoter olaquindox increases pathogen susceptibility in fish by inducing gut microbiota dysbiosis.

Authors:  Suxu He; Quanmin Wang; Shuning Li; Chao Ran; Xiaoze Guo; Zhen Zhang; Zhigang Zhou
Journal:  Sci China Life Sci       Date:  2017-06-30       Impact factor: 6.038

6.  The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon.

Authors:  Katrina R Grau; Shu Zhu; Stefan T Peterson; Emily W Helm; Drake Philip; Matthew Phillips; Abel Hernandez; Holly Turula; Philip Frasse; Vincent R Graziano; Craig B Wilen; Christiane E Wobus; Megan T Baldridge; Stephanie M Karst
Journal:  Nat Microbiol       Date:  2019-11-25       Impact factor: 17.745

7.  Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection.

Authors:  John Goulding; Alexandra Godlee; Seema Vekaria; Markus Hilty; Robert Snelgrove; Tracy Hussell
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

8.  Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.

Authors:  François Coulombe; Stéphanie Fiola; Shizuo Akira; Yvon Cormier; Jean Gosselin
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

9.  Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.

Authors:  Vanessa C Harris; George Armah; Susana Fuentes; Katri E Korpela; Umesh Parashar; John C Victor; Jacqueline Tate; Carolina de Weerth; Carlo Giaquinto; Willem Joost Wiersinga; Kristen D C Lewis; Willem M de Vos
Journal:  J Infect Dis       Date:  2016-10-31       Impact factor: 5.226

10.  Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons.

Authors:  Elisa Deriu; Gayle M Boxx; Xuesong He; Calvin Pan; Sammy David Benavidez; Lujia Cen; Nora Rozengurt; Wenyuan Shi; Genhong Cheng
Journal:  PLoS Pathog       Date:  2016-05-05       Impact factor: 6.823

View more
  2 in total

1.  Dietary supplementation of exopolysaccharides from Lactobacillus rhamnosus GCC-3 improved the resistance of zebrafish against spring viremia of carp virus infection.

Authors:  Mingxu Xie; Yu Li; Rolf Erik Olsen; Einar Ringø; Yalin Yang; Zhen Zhang; Chao Ran; Zhigang Zhou
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

2.  Response of gut microbiota to feed-borne bacteria depends on fish growth rate: a snapshot survey of farmed juvenile Takifugu obscurus.

Authors:  Xingkun Jin; Ziwei Chen; Yan Shi; Jian-Fang Gui; Zhe Zhao
Journal:  Microb Biotechnol       Date:  2021-01-04       Impact factor: 5.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.